M&A / Cross-border Acquisition

Gujarat Themis Biosyn announces acquisition of 100% equity in MicroBiopharm Japan Co through its Japanese subsidiary. The transaction valued at JPY 21.5 billion (INR 1,300 crores) aims to transform GT